S09 E09: Boehringer’s Christoph von der Goltz on setbacks and success in R&D
EMJ GOLD: Pharma marketing, medical & more
Release Date: 04/01/2025
S09 E09: Boehringer’s Christoph von der Goltz on setbacks and success in R&D
EMJ GOLD: Pharma marketing, medical & more
How can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week’s episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim. Together, he and Jade explore the ins and outs of drug failure, whether to pivot or persevere after an R&D setback, how to better break the stigma of mental illness and much more. A little more on EMJ GOLD’s guest… Christoph von der Goltz is Global Head of Medicine...
info_outline
S09 E08: HBA STAR Rebecca Vermeulen on purpose, passion and patients
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade this week as they delve into lessons in leadership and patient centricity with Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025. Rebecca shares her journey from pharmacist to industry leader, discussing her approach to leadership, the current landscape for women in pharma and what effective patient centricity looks like in practice. A little more on EMJ GOLD’s guest Rebecca was recently awarded the STAR prize by the Healthcare Businesswomen’s Association in recognition of her outstanding...
info_outline
S09 E07: DeepHealth’s Naiara Martínez Cabrera on AI’s role in radiology
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade as they uncover how AI is shaking up the radiology space and beyond with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. Together, Naiara and Jade explore what first drew the marketing leader to the healthcare sector, why radiology in particular has seen such a boost from artificial intelligence, what other therapy areas can learn from space and much more. A little more on EMJ GOLD’s guest… Naiara Martínez Cabrera is Vice President of Global Marketing, DeepHealth, where she has been since the company’s inception in 2023. Prior to this...
info_outline
S09 E06: Boston Scientific’s Angelo Auricchio on what’s next for heart health
EMJ GOLD: Pharma marketing, medical & more
This week, join Isabel and Jade as they explore what’s on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific. He and Isabel discuss Angelo’s recent career change into the industry, how technology could reform the UK’s NHS, the role of remote monitoring in patient wellbeing and more. A little more on EMJ GOLD’s guest… Angelo Auricchio was appointed Chief Medical Officer, Rhythm Management, Boston Scientific in September 2024, where he works across the...
info_outline
S09 E05: The HBA’s Mary Stutts on tackling bias for better women’s health
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade as they explore the persistent misunderstandings of women’s health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen’s Association. In this episode, Mary unpacks the key findings of the HBA’s latest report, which exposes critical gaps in doctors’ understanding of women’s health. She discusses the root causes, the real-world consequences and what the pharmaceutical industry must do to drive meaningful change. A little more on EMJ GOLD’s guest… Mary is the CEO of the HBA, a global organisation with a mission is...
info_outline
S09 E04: Does interactivity boost memory, recall and retention?
EMJ GOLD: Pharma marketing, medical & more
Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies and ultimately improves patient care. Read our article exploring the topic further . And if you’re interested to see how interactive works in the medical context, check out the interactive article mentioned .
info_outline
S09 E03: J&J’s Martin Price on World Cancer Day 2025 – Part 2
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space. In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and...
info_outline
S09 E02: J&J's Martin Price on World Cancer Day
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this year’s theme ‘United by Unique’, the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in...
info_outline
S09 E01: Lundbeck’s Charl van Zyl on a new era in neurology
EMJ GOLD: Pharma marketing, medical & more
The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions. Together, Charl and Isabel explore his career journey in the pharmaceutical industry, Lundbeck’s plans for the future, the role of digital health technology and much more. A little more on EMJ GOLD’s guest... Charl van Zyl joined...
info_outline
The 2025 pharma forecast
EMJ GOLD: Pharma marketing, medical & more
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD’s guests… Jennifer Schranz is the Senior Vice President, Global Head of Rare...
info_outlineHow can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week’s episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim.
Together, he and Jade explore the ins and outs of drug failure, whether to pivot or persevere after an R&D setback, how to better break the stigma of mental illness and much more.
A little more on EMJ GOLD’s guest…
Christoph von der Goltz is Global Head of Medicine Central Nervous System and Emerging Areas at Boehringer Ingelheim. He has more than 15 years of experience in a variety of roles in pharmaceutical R&D. He is also a board-certified psychiatrist with more than 10 years of clinical experience in neurology and psychiatry and academic research in preclinical, clinical and public health projects in Germany and Sweden.